Acacia latest life sciences play is about intangible assets - but not patents
Acquisition of stake in data-focused, medtech business, Sensyne is another sign of the NPE’s push to diversify its holdings
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.